 WASHINGTON, Dec. 1, 2020 PRNewswire -- Vanda Pharmaceuticals Inc. Vanda Nasdaq: VNDA today announced that the U.S. Food and Drug Administration FDA has approved HETLIOZ tasimelteon capsule and liquid formulations for the treatment of adults and children, respectively, with... 